Anzeige
Mehr »
Samstag, 13.09.2025 - Börsentäglich über 12.000 News
Diese Aktie sichert sich Exklusiv-Partnerschaft mit Babcock für Ukraine-Defence - Neubewertung voraus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
97 Leser
Artikel bewerten:
(0)

Allen Carr's Easyway Supports World Health Organisation's Call To Regulate E-cigarettes and To Prevent Their Uptake By Children, Adolescents And Other Vulnerable Groups

LONDON, July 27, 2021 /PRNewswire/ -- Allen Carr's Easyway, who are endorsed by WHO and continue to work with them on their Commit to Quit Campaign in more than a dozen countries worldwide, is fully supportive of the newly released World Health Organisation (WHO) report on electronic nicotine delivery systems, such as e-cigarettes. The report finds that children who use these products are up to twice as likely to use tobacco products in the future. As such, both WHO and Allen Carr's Easyway recommend tighter regulations to stop non-smokers from starting to use them, to prevent renormalisation of smoking in the community and to protect future generations.

Allen Carr's Easyway logo

For the first time, the WHO report on The Global Tobacco Epidemic, presents new data on electronic nicotine delivery systems, such as 'e-cigarettes'. These products are often marketed to children and adolescents by the tobacco and related industries that manufacture them, using appealing flavours and misleading claims about the products.

Allen Carr's Easyway, the world's most successful stop smoking method, is available in 50 countries and has already helped more than 50 million smokers worldwide over its 35-year history. Allen Carr's Easyway is a clinically proven completely drug-free form of talking therapy with two Randomised controlled Trials (RCTs). The organisation has worked closely with WHO in the past, to support efforts to reduce tobacco addiction.

Allen Carr's Easyway Addiction Centres already work with a number of forward-thinking, progressive Local Health Authorities in the UK and are in advanced discussions with the NHS and wider health organisations. National Institute for Health and Care Excellence (NICE) has confirmed that Allen Carr's Easyway is a non-pharmacological option that can be offered to smokers seeking help to quit via local health authority stop smoking services.

With regards to e-cigarettes and vaping, WHO cites that "switching isn't quitting" and Allen Carr's Easyway is a drug free clinically proven alternative to smoking & vaping that they are happy to deploy as part of their 'Commit to Quit 2021 Campaign' detailed here.

John Dicey, Global CEO for Allen Carr's Easyway, who has been working with and advising the World Health Organisation's Commit to Quit 2021 Campaign:
"Allen Carr's Easyway has consistently called for greater regulation of e-cigarettes, to prevent them being marketed to children and adolescents by the tobacco industry, so it's fantastic to see WHO endorsing this and WHO should be congratulated on the progress they have made since 2007, as highlighted in the report.Allen Carr's Easyway supports any method that helps smokers to quit, but I'm shocked that WHO's report indicates that kids who use vaping devices are up to twice as likely to use tobacco products in the future. The e-cigarette industry has operated almost entirely unregulated in the UK, yet is fully supported by NICE & Public Health England, who have been extremely slow to support Allen Carr's Easyway, a drug-free, clinically proven treatment, perfectly safe for quitting smoking and nicotine addiction. The success of the method and the fact that it works means we are breaking through, but when the Director General of the World Health Organisation warns the world's governments that they should be protecting their citizens from the harm of vaping devices, I would call on NICE & Public Health England to add a drug-free, clinically proven, safe method of quitting smoking to the options provided to UK smokers who approach the NHS and local health authority quit smoking services for help."

A World Health Organisation spokesperson comments:
"Randomized controlled trials show that there are proven ways for drug free smoking cessation, for example, intensive behavioural support with individual or group counselling, [Allen Carr's Easyway] is one of the effective interventions. In fact, WHO will soon publish a paper calling on countries to invest in tobacco cessation with the recommended interventions."

Dr Tedros Adhanom Ghebreyesus, WHO Director-General comments:
"Nicotine is highly addictive. Electronic nicotine delivery systems are harmful, and must be better regulated. Where they are not banned, governments should adopt appropriate policies to protect their populations from the harms of electronic nicotine delivery systems, and to prevent their uptake by children, adolescents and other vulnerable groups."

www.allencarr.com

Notes to Editors:

  • John Dicey is available for media interview
  • WHO report on The Global Tobacco Epidemic, is available from 27th July via www.who.int

Logo - https://mma.prnewswire.com/media/1582126/Allen_Carrs_Easyway_logo.jpg

© 2021 PR Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.